News and Publications

2021 ASTRO Annual Meeting Press Kit

The 2021 ASTRO Annual Meeting – the leading meeting in radiation oncology – will be held October 24-27 at McCormick Place West in Chicago. Led by ASTRO President Laura A. Dawson, MD, FASTRO, the meeting is organized around the theme, “Embracing Change, Advancing Person-Centered Care.” New results from clinical trials and other research studies will be presented in conjunction with educational panels, keynote addresses and other special sessions. For more information, view the meeting launch press release.

ASTRO is working closely with McCormick Place and the City of Chicago to ensure that COVID-19 safety protocols are in place to foster a healthy and safe learning experience for attendees. COVID-19 vaccination (or a negative COVID-19 test for medical exemptions) will be required for all meeting participants, and masks will be required throughout the convention center. Additional enhanced safety measures for the meeting include modified layouts to allow spacing in session rooms, a reconfigured exhibit hall with wider aisleways, cleaning/sanitizing rooms between sessions, touch-free technology and hand sanitizing stations throughout the convention center. More information is available at www.astro.org/safety.

News Briefings

ASTRO news briefings will highlight top-rated abstracts presented at the Annual Meeting and address topical issues that impact cancer care. All briefings for the 2021 meeting will be held in room 474B of McCormick Place West in Chicago, with a live webcast for off-site journalists.

The news briefing schedule is as follows:

Monday, October 25, 9:30 – 10:30 a.m. Central time

  • "Primary endpoint analysis of a randomized phase III Trial of hypofractionated versus conventional post-prostatectomy radiotherapy: NRG Oncology GU003," presented by Mark K. Buyyounouski, MD, Stanford University (Abstract 3)
  • "Validation of a 22-gene genomic classifier in the NRG Oncology/RTOG 9202, 9413 and 9902 phase III randomized trials: A biopsy-based individual patient meta-analysis in high-risk prostate cancer," presented by Paul L. Nguyen, MD, Dana-Farber/Brigham and Women's Cancer Center (Abstract 95)
  • "Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast," presented by C. Jillian Tsai, MD, PhD, Memorial Sloan Kettering Cancer Center (Abstract LBA-3)

Monday, October 26, 2:00 – 3:00 p.m. Central time

  • "Overall survival from a prospective multi-institutional trial to resolve Black-white disparities in the treatment of early-stage breast and lung cancer," presented by Matthew Manning, MD, FASTRO, Cone Health (Abstract 53)
  • "Time-driven activity-based costing as a method for estimating the practice-level and national cost burden of treatment-related prior authorization for academic radiation oncology practices," presented by Brian S. Bingham, MD, Vanderbilt University Medical Center (Abstract 136)
  • "Bridge-to-transplant external-beam radiation therapy in patients with hepatocellular carcinoma: A utilization analysis of the United Network for Organ Sharing (UNOS) database," presented by Nima Nabavizadeh, MD, Oregon Health & Science University (Abstract 2078)

Tuesday, October 27, 2:00 – 3:00 p.m. Central time

This briefing will feature short presentations on promising technologies and approaches for person-centered care in radiation oncology, followed by remarks from ASTRO President Laura A. Dawson, MD, FASTRO.

  • Impact of Pediatric Radiation Oncology with Movie Induced Sedation Effect (PROMISE) on patient movement and general anesthesia use in pediatric radiation therapy, presented by Jeffrey T. Chapman, University of Texas Southwestern Medical Center (Abstract 179)
  • 3-D virtual reality volumetric imaging review in cancer patients’ understanding and education of their disease and treatment, presented by Douglas E. Holt, MD, Eastern Idaho Regional Medical Center (Abstract 2289)
  • Development and impact of a virtual PSA monitoring clinic for follow-up of prostate cancer patients, presented by Richard Boyajian, MSN, RN, NP, Dana-Farber/Brigham and Women's Cancer Center (Abstract 125)
  • Site-specific education using digital media to improve patients’ understanding of the radiotherapy trajectory: An interventional study, presented by Hussain Almerdhemah, B.App.Sc-RT, King Faisal Specialist Hospital and Research Centre (Abstract 2132)

Press Facilities in Chicago: ASTRO will host an on-site press office in McCormick Place West room 474A, open Sunday, October 24, through Wednesday, October 27, from 8:00 to 5:00 pm Central time. A printer and coffee will be provided. Reporters who join us in Chicago should pick up their meeting badges in the press office, not at the registration desk.

Press Registration

ASTRO provides complimentary meeting registration to credentialed news professionals representing media organizations for the express purpose of gathering news and information to produce editorial coverage of the ASTRO Annual Meeting.

Complimentary registration is open to representatives of print, broadcast and web-based media, including health care trade media, as well as public information officers from educational institutions, government agencies and nonprofit cancer research organizations presenting research at the ASTRO Annual Meeting. Applicants may be asked to provide media credentials, a letter of assignment, bylined articles and/or additional information to complete processing of their registration request.

Exhibitors are not permitted to register as press unless they can provide proof of editorial assignment from an accredited news organization that meets the above criteria. Public relations, marketing and/or advertising representatives, financial analysts, book publishers and book authors, and individuals from communications, print or online promotion services are welcome to register as regular attendees, however, they are not permitted to register as press. ASTRO reserves the right to bar from this and future meetings any journalist who misuses press privileges to engage in activities other than journalistic pursuits.

Embargo Policy and Access to Abstracts

All abstracts to be presented at the ASTRO Annual Meeting are embargoed until 5:00 p.m. Central time on Friday, October 22, 2021. For more details, view the full embargo policy. Contact ASTRO's media relations team with questions about the embargo policy or for press access to embargoed materials.

Abstracts will be available online in the Online Conference Planner and MyASTROApp when the embargo lifts. Abstracts also will be published in the International Journal of Radiation Oncology • Biology • Physics (Red Journal) at that time.

For More Information